In March 2015, Cellular Dynamcis was acquired by FujiFilm Holdings and in May ceased trading. Cellular Dynamics International, Inc. (CDI) is developing the next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPSC technology, the production of pluripotent stem cell lines from adult tissue. Cellular Dynamics International, Inc. (CDI) is developing stem cell technologies for in vitro drug development, in vivo cellular therapeutics, and stem cell banking. CDI harnesses its unique manufacturing technology to produce differentiated tissue cells in industrial quality, quantity and purity from any individualâs stem cell line created from a standard blood draw. CDI was founded by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison
